AU2002321556A1 - Inhibition of replication factor c - Google Patents

Inhibition of replication factor c

Info

Publication number
AU2002321556A1
AU2002321556A1 AU2002321556A AU2002321556A AU2002321556A1 AU 2002321556 A1 AU2002321556 A1 AU 2002321556A1 AU 2002321556 A AU2002321556 A AU 2002321556A AU 2002321556 A AU2002321556 A AU 2002321556A AU 2002321556 A1 AU2002321556 A1 AU 2002321556A1
Authority
AU
Australia
Prior art keywords
inhibition
replication factor
replication
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002321556A
Inventor
Lisa Ann Anderson
Neil Donald Perkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
UNV DUNDEE
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNV DUNDEE, University of Dundee filed Critical UNV DUNDEE
Publication of AU2002321556A1 publication Critical patent/AU2002321556A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2002321556A 2001-08-29 2002-08-29 Inhibition of replication factor c Abandoned AU2002321556A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0120943.6 2001-08-29
GBGB0120943.6A GB0120943D0 (en) 2001-08-29 2001-08-29 Inhibition of replication factor C
PCT/GB2002/003953 WO2003020754A2 (en) 2001-08-29 2002-08-29 Inhibition of replication factor c

Publications (1)

Publication Number Publication Date
AU2002321556A1 true AU2002321556A1 (en) 2003-03-18

Family

ID=9921170

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002321556A Abandoned AU2002321556A1 (en) 2001-08-29 2002-08-29 Inhibition of replication factor c

Country Status (3)

Country Link
AU (1) AU2002321556A1 (en)
GB (2) GB0120943D0 (en)
WO (1) WO2003020754A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0303397D0 (en) * 2003-12-17 2003-12-17 Index Pharmaceuticals Ab Compounds and method for RNA interference

Also Published As

Publication number Publication date
WO2003020754A3 (en) 2003-05-15
GB0404039D0 (en) 2004-03-31
GB0120943D0 (en) 2001-10-17
GB2394953A (en) 2004-05-12
GB2394953B (en) 2005-12-14
WO2003020754A2 (en) 2003-03-13

Similar Documents

Publication Publication Date Title
AU2002363005A1 (en) Derivatives of uk-2a
AU2002339348A1 (en) Inhibition of STAT-1
AU2002360988A1 (en) Adhesion inhibition of moulds
AU2002360437A1 (en) Reducing myelin-mediated inhibition of axon regeneration
AU2002326949A1 (en) Method for the inhibition of methanogenesis
AU2003222197A1 (en) Inhibition of rna function
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AUPQ629000A0 (en) Inhibition of fungi
AU2003299137A1 (en) Inhibition of metallo-beta-lactamase
AU2002321556A1 (en) Inhibition of replication factor c
AU2003287388A1 (en) Inhibition of hiv-1 replication
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2002305868A1 (en) Inhibitors of reggamma
GB0100151D0 (en) Methods of sputtering
AU2002355739A1 (en) Preparation and use of alpha-keto phosphonates
AU2002357159A1 (en) MANUFACTURE OF TRIALKYLALUMINUM COMPOUNDS AND Alpha-ALCOHOLS
AU2001286584A1 (en) Inhibition of protein-protein interaction
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002258749A1 (en) Inhibitors of glycosaminoglycans
AU2002303162A1 (en) Il-1ss inhibition for myeloma and related disorders
EP1238585B8 (en) Use of esterquats
AU2002307475A1 (en) Inhibition of jun kinase
AU2001231983A1 (en) Delayed release of fluids

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase